Cargando…
Erratum to “Inositols in the Treatment of Insulin-Mediated Diseases”
Autores principales: | Muscogiuri, Giovanna, Palomba, Stefano, Laganà, Antonio Simone, Orio, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5164898/ https://www.ncbi.nlm.nih.gov/pubmed/28044078 http://dx.doi.org/10.1155/2016/6189820 |
Ejemplares similares
-
Inositols in the Treatment of Insulin-Mediated Diseases
por: Muscogiuri, Giovanna, et al.
Publicado: (2016) -
Erratum: The pan-class I phosphatidyl-inositol-3 kinase inhibitor NVP-BKM120 demonstrates anti-leukemic activity in acute myeloid leukemia
por: Allegretti, Matteo, et al.
Publicado: (2016) -
Erratum to: Myo-inositol is a promising treatment for the prevention of ovarian hyperstimulation syndrome (OHSS): an animal study
por: Turan, Guluzar Arzu, et al.
Publicado: (2016) -
Erratum to: The Economic Burden of Insulin-Related Hypoglycemia in Spain
por: Parekh, Witesh, et al.
Publicado: (2017) -
Erratum for “Ultra‐long‐acting recombinant insulin for the treatment of diabetes mellitus in dogs”
Publicado: (2023)